Bellflower, CALIFORNIA5 Active Studies

Major Depressive Disorder Clinical Trials in Bellflower, CALIFORNIA

Find 5 actively recruiting major depressive disorder clinical trials in Bellflower, CALIFORNIA. Connect with local research sites and explore new treatment options.

5
Active Trials
5
Sponsors
2,459
Enrolling

Recruiting Major Depressive Disorder Studies in Bellflower

RecruitingBellflower, CALIFORNIANCT06029439

Study to Assess the Safety and Effectiveness of NMRA-335140-501

This is a 52-week open-label extension (OLE) study that will evaluate the safety, tolerability, and effectiveness of NMRA-335140 in participants with major depressive disorder (MDD). Participants who ...

1,000 participants
Neumora Therapeutics, Inc.
View Study Details
RecruitingBellflower, CALIFORNIANCT05711940

Efficacy, Safety, and Tolerability of Two Administrations of COMP360 in Participants With TRD

Efficacy, Safety, and Tolerability of two administrations of COMP360 in participants with treatment-resistant depression (TRD)...

568 participants
COMPASS Pathways
View Study Details
RecruitingBellflower, CALIFORNIANCT06223880

A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms

This is a randomized, double-blind, active-controlled, multi-center study to evaluate the efficacy of AXS-05, compared to bupropion, in preventing the relapse of depressive symptoms in subjects with m...

350 participants
Axsome Therapeutics, Inc.
View Study Details
RecruitingBellflower, CALIFORNIANCT05922878

Study of ALTO-300 in MDD

The purpose of this study is to determine efficacy differences between ALTO-300 and placebo, used adjunctively to an antidepressant, related to patient characteristics....

321 participants
Alto Neuroscience
View Study Details
RecruitingBellflower, CALIFORNIANCT06564818

"A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder"

The purpose of this study is to examine the efficacy, safety, and tolerability of CYB003 compared to matching placebo as adjunctive treatment in participants with MDD....

220 participants
Cybin IRL Limited
View Study Details

About Major Depressive Disorder Clinical Trials in Bellflower

Major depressive disorder (MDD) is a severe form of depression characterized by persistent sadness, loss of interest, and impaired daily functioning. Treatment-resistant depression (TRD) affects patients who do not respond to standard therapies. Novel treatments like ketamine, psilocybin, and neuromodulation are being studied.

There are currently 5 major depressive disorder clinical trials recruiting participants in Bellflower, CALIFORNIA. These studies are seeking a combined 2,459 participants. Research is being sponsored by Neumora Therapeutics, Inc., COMPASS Pathways, Axsome Therapeutics, Inc. and 2 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Major Depressive Disorder Clinical Trials in Bellflower — FAQ

Are there major depressive disorder clinical trials in Bellflower?

Yes, there are 5 major depressive disorder clinical trials currently recruiting in Bellflower, CALIFORNIA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Bellflower?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Bellflower research site will contact you about next steps.

Are clinical trials in Bellflower free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Bellflower studies also compensate for your time and travel.

What major depressive disorder treatments are being tested?

The 5 active trials in Bellflower are testing new therapies including novel drugs, biologics, and treatment approaches for major depressive disorder.

Data updated March 2, 2026 from ClinicalTrials.gov